Characterization of the interaction between Robo1 and heparin and other glycosaminoglycans
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (GM-38060)
- National Institutes of Health (RR005351/GM103390)
- National Institutes of Health (R01HL093339)
This publication has 60 references indexed in Scilit:
- NMR Characterization of Immunoglobulin G Fc Glycan Motion on Enzymatic SialylationBiochemistry, 2012
- Heparin-induced Leukocytosis Requires 6-O-Sulfation and Is Caused by Blockade of Selectin- and CXCL12 Protein-mediated Leukocyte Trafficking in MiceJournal of Biological Chemistry, 2012
- Biophysical characterization of glycosaminoglycan-IL-7 interactions using SPRBiochimie, 2012
- Robo4 Cooperates with Cxcr4 to Specify Hematopoietic Stem Cell Localization to Bone Marrow NichesCell Stem Cell, 2011
- Compositional Analysis of Heparin/Heparan Sulfate Interacting with Fibroblast Growth Factor·Fibroblast Growth Factor Receptor ComplexesBiochemistry, 2009
- Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeabilityNature Medicine, 2008
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007
- Engineering and characterization of a superfolder green fluorescent proteinNature Biotechnology, 2005
- Common mechanisms of nerve and blood vessel wiringNature, 2005
- The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factorsNature, 2001